Allopartis Biotechnologies develops tailored industrial and therapeutic proteins using the AlloScreen, an innovative high-throughput enzyme optimization platform.
By eliminating the need for cell culture and robotic screening, our patented system is dramatically faster than conventional methods. Built on next-generation DNA sequencing concepts, the platform integrates three components—emulsions, directed evolution, and solid substrate particles—with an innovative approach to selecting enhanced proteins.
By eliminating the need for cell culture and robotic screening, our patented system is dramatically faster than conventional methods. Built on next-generation DNA sequencing concepts, the platform integrates three components—emulsions, directed evolution, and solid substrate particles—with an innovative approach to selecting enhanced proteins.
